BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15121253)

  • 1. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound.
    Wu F; Wang ZB; Jin CB; Zhang JP; Chen WZ; Bai J; Zou JZ; Zhu H
    Ultrasound Med Biol; 2004 Apr; 30(4):511-7. PubMed ID: 15121253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
    Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
    Jeng KS; Sheen IS; Tsai YC
    Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction.
    Liu Y; Wu MC; Qian GX; Zhang BH
    Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):72-6. PubMed ID: 14607627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
    Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
    Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
    Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood.
    Yang SZ; Dong JH; Li K; Zhang Y; Zhu J
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):227-33. PubMed ID: 15908320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
    Jeng KS; Sheen IS; Tsai YC
    Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
    Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR.
    Guo J; Yao F; Lou Y; Xu C; Xiao B; Zhou W; Chen J; Hu Y; Liu Z
    J Clin Gastroenterol; 2007 Sep; 41(8):783-8. PubMed ID: 17700428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver.
    Funaki NO; Tanaka J; Seto SI; Kasamatsu T; Kaido T; Imamura M
    Hepatology; 1997 Mar; 25(3):564-8. PubMed ID: 9049199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment.
    Zhou Q; Zhu XQ; Zhang J; Xu ZL; Lu P; Wu F
    Ultrasound Med Biol; 2008 Jan; 34(1):81-7. PubMed ID: 17854983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AFP mRNA expression in peripheral blood correlates with metastasis of hepatocellular carcinoma].
    Jiang Y; Yang Z; Hu J
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):38-41. PubMed ID: 11776794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY
    Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.
    Li YY; Sha WH; Zhou YJ; Nie YQ
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2148-54. PubMed ID: 18031373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study.
    Wong IH; Chan AT; Johnson PJ
    Clin Cancer Res; 2000 Jun; 6(6):2183-8. PubMed ID: 10873067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.